Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
Titel:
Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
Auteur:
Schmidt, M. Rüttinger, D. Sebastian, M. Hanusch, C.A. Marschner, N. Baeuerle, P.A. Wolf, A. Göppel, G. Oruzio, D. Schlimok, G. Steger, G.G. Wolf, C. Eiermann, W. Lang, A. Schuler, M.